Analysis of Adverse Events in Weight Loss Program in Combination with 'Gamitaeeumjowee-Tang' and Low-Calorie Diet |
Yoon, Na-Ra
(Nubebe Korean Medical Clinic)
Yoo, Young-Jae (Nubebe Korean Medical Clinic) Kim, Min-ji (Nubebe Korean Medical Clinic) Kim, Seo-Young (Nubebe Korean Medical Clinic) Lim, Young-Woo (Nubebe Korean Medical Clinic) Lim, Hyung Ho (College of Korean Medicine, Gachon University) Park, Young-Bae (Nubebe Mybou Research Institute) |
1 | Korean Society for the Study of Obesity. Clinical bariatrics. 3rd ed. Seoul : Korea Medical Book. 2008 : 143. |
2 | Ministry of Health and Welfare. Korea Centers for Disease Control and Prevention. Korea Health Statistics 2016: Korea National Health Statistics and Nutrition Examination Survey (KNHANESVII-1) [Internet]. Seoul(KR): KCDC; 2016 [cited 2018 Jan 4]. Available from: URL: https://knhanes.cdc.go.kr/knhanes/sub04/sub04_03.do?classType=7. |
3 | Korean Society for Health Promotion and Disease Prevention. Korean Society for Health Promotion and Disease Prevention 2012 spring academic conference. Seoul : Korean Society for Health Promotion and Disease Prevention. 2012 : 163-8. |
4 | Kim KK. Safety of anti-obesity drugs approved for long-term use. Korean J Obes. 2015 ; 24(1) : 17-27. DOI |
5 | Jeong JW, Cho SW. Trend research of the human body-oriented obesity studies on Korean medicine. J Korean Med Rehab. 2016 ; 26(1) : 49-61. DOI |
6 | Hwang MJ, Shin HD, Song MY. Literature review of herbal medicines on treatment of obesity since 2000; mainly about Ephedra Herba. J Korean Med Obes Res. 2007; 7(1) : 39-54. |
7 | Lee JM. Longevity and life preservation in Eastern medicine. 2nd. Seoul : Hanglimsa. 1993 : 19-24, 137-41. |
8 | Park KM, Song YK, Lim HH, Lee JA, Ko HY, Park JH, et al. Review on the research relative to Taeeumjowui-tang (Taiyintiaowei-tang). J Korean Med Obes Res. 2009 ; 9(1) : 23-36. |
9 | Lee JE, Song YK, Lim HH. Clinical trial of Taeeumjowui-tang (Taiyintiaowei-tang) on obese patients: randomized, double blind, placebo-controlled study. J Oriental Rehab Med. 2010 ; 20(4) : 197-213. |
10 | Park SJ, Won N, Cheon C, Park JS, Jang BH, Shin Y, et al. Efficacy and safety of taeeumjowi-tang in obese Korean adults: a double-blind, randomized, and placebo-controlled pilot trial. Evid Based Complement Alternat Med. 2013 ; 2013 : 498935. doi: 10.1155/2013/498935. Epub 2013 Aug 26. |
11 | Seo NJ, Nam DW, Lee EO, Sim BS, Ahn KS, Kim SH. Clinical study of Gamitaeeumjowi-tang for obese patients. Korean J Oriental Physiology & Pathology. 2008 ; 22(2) : 446-52. |
12 | Song MY, Kim HJ, Lee MJ. The safety guidelines for use of Ma-huang in obesity treatment. J Korean Med Obes Res. 2006; 6(2) : 17-27. |
13 | Korea Institute of Drug Safety & Risk Management. Adverse Drug Reaction Assessment Report. 1st ed. Seoul : Korea Institute of Drug Safety & Risk Management. 2013 : 60-3. |
14 | Korea Institute of Oriental Medicine. KMCPG-obesity. 1st ed. Seoul : Elsevier Korea. 2016 : 84-9. |
15 | Korean Society for the Study of Obesity. Clinical Practice Guidelines for Obesity 2012. 1st ed. Seoul : KOSSO. 2012 : 61-71. |
16 | World Health Organization-Uppsala Monitoring Centre (WHO-UMC). Causality categories [Internet]. Uppsala (Sweden): World Health Organization-Uppsala Monitoring Centre (WHO-UMC); 2018. [cited 2012 Oct 22]. Available from: https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf. |
17 | Kim M, Han CH. Analysis of herbal-drug-associated adverse drug reactions using data from spontaneous reporting system in electronic medical records. J Korean Med. 2015 ; 36(1) : 45-60. DOI |
18 | Kyung EJ, Ryu JH, Kim EY. Evaluation of adverse reactions to contrast media in the hospital. Br J Radiol. 2013 ; 86(1032) : 20130418. DOI |
19 | Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997 ; 277 : 301-6. DOI |
20 | Korea Institute of Drug Safety & Risk Management. Terminology Guide for Reporting Adverse Drug Reactions. Seoul : Korea Institute of Drug Safety & Risk Management. 2014 : 1-6. |
21 | Chang MS, Shim KJ, Kim HY, Park EH, Ko EB, Choi BJ et al. Acute oral toxicity of Taeumjowi-tang in SD rats. Korean J Oriental Physiology & Pathology. 2008 ; 22(6) : 1439-43. |
22 | Jang IS, Yang CS, Hwang EH. The need for clinical practice guidelines in usage of Mahuang in weight loss. J Korean Med Obes Res. 2007 ; 7(1) : 23-9. |
23 | Jin YH, Kim KS, Han IY, Lee HB. Influence of prescribed Gamitaeeumjowi-tang on liver function: prospective single-center pilot study. J Korean Med Obes Res. 2010 ; 10(1) : 29-40. |
24 | Kim HJ, Kim JY. Clinical report about the adverse reactions of Taeeumin.Soeumin.Soyangin by Taeeumjowi-tang. Korean J Oriental Physiology & Pathology. 2008 ; 22(6) : 1600-5. |
25 | Jo GW, OK JM, Kim SY, Lim YW. Review on the efficacy and safety of Mahuang and ephedrine in the treatment of obesity-focused on RCT. J Korean Med. 2017 ; 38(3) : 170-84. DOI |
26 | Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003 ; 289(12) : 1537-45. DOI |
27 | Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord. 2002 ; 26(5) : 593-604. DOI |
28 | Greenway FL, Ryan DH, Bray GA, Rood JC, Tucker EW, Smith SR. Pharmaceutical cost savings of treating obesity with weight loss medications. Obes Res. 1999 ; 7(6) : 523-31. DOI |
29 | Christensen P, Bliddal H, Riecke BF, Leeds AR, Astrup A, Christensen R. Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomized controlled trial. Obes. 2011 ; 1(1) : 31-40. |
30 | Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004 ; 140(10): 769-77. DOI |